Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special Drug Use-results Survey of RIONA Tablets in Pregnant Patients with Iron Deficiency Anemia
jRCT2031210322Completed
- Sponsor
- Japan Tobacco
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of norethindrone + ethinyl estradiol in iron deficiency anemia (IDA), sponsored by Japan Tobacco. Primary endpoint: Drug safety in pregnant patients with iron deficiency anemia. Started Dec 2021; status: completed.
02
Drugs
norethindrone + ethinyl estradiol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCT2031210322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210322.